| Jeanette Cochran, NP | |
|
301 E Maumee St, Angola, IN 46703-2012 | |
| (260) 667-5635 | |
| (260) 665-8852 |
| Full Name | Jeanette Cochran |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 14 Years |
| Location | 301 E Maumee St, Angola, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720305782 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 71003238A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Parkview Health System Inc | 2163336967 | 1167 |
News Archive
STENTYS S.A., which develops innovative stents to treat Acute Myocardial Infarction (AMI), announced today that it has begun the international APPOSITION III study of its self-apposing stent, with 50 patients already enrolled out of a total of 500. The trial primary endpoint is Major Adverse Cardiac Events at 12 months post-procedure.
Catherine Aaron and Gabrielle Beaudry were 17 when they knocked on the door of the laboratory of Alex Parker, a neuroscience researcher at the University of Montreal Hospital Research Centre. While students at Collège Jean-de-Brébeuf in Montreal, they were looking for a mentor for an after-school research project. Two and half years later, the results of this scientific adventure were published today in the Journal of Agricultural and Food Chemistry.
ESC Guidelines published today on infective endocarditis boost the role of imaging in diagnosis of this deadly disease.
Synthego, a leading provider of genome engineering solutions, officially launches today. Synthego's flagship product line, CRISPRevolution, features synthetic guide RNA products designed to accelerate CRISPR/Cas9 and Cpf1 genome engineering research. CRISPRevolution is the first product line to offer economical access to fully synthetic RNA for high fidelity editing and increased precision in genome editing.
› Verified 6 days ago
| Entity Name | Parkview Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932130952 PECOS PAC ID: 2163336967 Enrollment ID: O20031117000288 |
News Archive
STENTYS S.A., which develops innovative stents to treat Acute Myocardial Infarction (AMI), announced today that it has begun the international APPOSITION III study of its self-apposing stent, with 50 patients already enrolled out of a total of 500. The trial primary endpoint is Major Adverse Cardiac Events at 12 months post-procedure.
Catherine Aaron and Gabrielle Beaudry were 17 when they knocked on the door of the laboratory of Alex Parker, a neuroscience researcher at the University of Montreal Hospital Research Centre. While students at Collège Jean-de-Brébeuf in Montreal, they were looking for a mentor for an after-school research project. Two and half years later, the results of this scientific adventure were published today in the Journal of Agricultural and Food Chemistry.
ESC Guidelines published today on infective endocarditis boost the role of imaging in diagnosis of this deadly disease.
Synthego, a leading provider of genome engineering solutions, officially launches today. Synthego's flagship product line, CRISPRevolution, features synthetic guide RNA products designed to accelerate CRISPR/Cas9 and Cpf1 genome engineering research. CRISPRevolution is the first product line to offer economical access to fully synthetic RNA for high fidelity editing and increased precision in genome editing.
› Verified 6 days ago
| Entity Name | Cameron Memorial Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770521478 PECOS PAC ID: 9234020835 Enrollment ID: O20040323001008 |
News Archive
STENTYS S.A., which develops innovative stents to treat Acute Myocardial Infarction (AMI), announced today that it has begun the international APPOSITION III study of its self-apposing stent, with 50 patients already enrolled out of a total of 500. The trial primary endpoint is Major Adverse Cardiac Events at 12 months post-procedure.
Catherine Aaron and Gabrielle Beaudry were 17 when they knocked on the door of the laboratory of Alex Parker, a neuroscience researcher at the University of Montreal Hospital Research Centre. While students at Collège Jean-de-Brébeuf in Montreal, they were looking for a mentor for an after-school research project. Two and half years later, the results of this scientific adventure were published today in the Journal of Agricultural and Food Chemistry.
ESC Guidelines published today on infective endocarditis boost the role of imaging in diagnosis of this deadly disease.
Synthego, a leading provider of genome engineering solutions, officially launches today. Synthego's flagship product line, CRISPRevolution, features synthetic guide RNA products designed to accelerate CRISPR/Cas9 and Cpf1 genome engineering research. CRISPRevolution is the first product line to offer economical access to fully synthetic RNA for high fidelity editing and increased precision in genome editing.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeanette Cochran, NP 416 E Maumee St, Angola, IN 46703-2015 Ph: (260) 667-5131 | Jeanette Cochran, NP 301 E Maumee St, Angola, IN 46703-2012 Ph: (260) 667-5635 |
News Archive
STENTYS S.A., which develops innovative stents to treat Acute Myocardial Infarction (AMI), announced today that it has begun the international APPOSITION III study of its self-apposing stent, with 50 patients already enrolled out of a total of 500. The trial primary endpoint is Major Adverse Cardiac Events at 12 months post-procedure.
Catherine Aaron and Gabrielle Beaudry were 17 when they knocked on the door of the laboratory of Alex Parker, a neuroscience researcher at the University of Montreal Hospital Research Centre. While students at Collège Jean-de-Brébeuf in Montreal, they were looking for a mentor for an after-school research project. Two and half years later, the results of this scientific adventure were published today in the Journal of Agricultural and Food Chemistry.
ESC Guidelines published today on infective endocarditis boost the role of imaging in diagnosis of this deadly disease.
Synthego, a leading provider of genome engineering solutions, officially launches today. Synthego's flagship product line, CRISPRevolution, features synthetic guide RNA products designed to accelerate CRISPR/Cas9 and Cpf1 genome engineering research. CRISPRevolution is the first product line to offer economical access to fully synthetic RNA for high fidelity editing and increased precision in genome editing.
› Verified 6 days ago
Brecken Gilbert, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 306 E Maumee St Ste 201, Angola, IN 46703 Phone: 260-667-2700 Fax: 260-667-2611 | |
Kelly Bireley, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 306 E Maumee St Ste 103, Angola, IN 46703 Phone: 260-667-5148 | |
Jayne S Sloan, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 301 E Maumee St, Angola, IN 46703 Phone: 260-675-7535 | |
Amber N Handshoe, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3270 Intertech Dr, Angola, IN 46703 Phone: 260-302-2622 Fax: 260-305-2655 | |
Mrs. Lauren A Laroe, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 200 Hoosier Dr Ste E, Angola, IN 46703 Phone: 260-665-9494 | |
Mrs. Audra Lehman, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3250 Intertech Dr, Suite A, Angola, IN 46703 Phone: 260-665-2646 | |
Carlene M Mcclurg, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 301 E Maumee St, Angola, IN 46703 Phone: 260-667-5635 Fax: 260-665-8852 |